[June 17, 2013]

Research and Markets: Bronchiolitis Obliterans - Pipeline Review, H1 2013

Research and Markets (http://www.researchandmarkets.com/research/xb4swd/bronchiolitis) has announced the addition of the "Bronchiolitis Obliterans - Pipeline Review, H1 2013" report to their offering.

'Bronchiolitis Obliterans - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Bronchiolitis Obliterans, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Bronchiolitis Obliterans.

Scope

- A snapshot of the global therapeutic scenario for Bronchiolitis Obliterans.

- A review of the Bronchiolitis Obliterans products under development by companies and universities/research institutes based n information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Bronchiolitis Obliterans pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

1. Bronchiolitis Obliterans Overview
2. Therapeutics Development
3. An Overview of Pipeline Products for Bronchiolitis Obliterans
4. Bronchiolitis Obliterans Therapeutics under Development by Companies, Universities/Institutes
5. Late Stage Products
6. Mid Clinical Stage Products
7. Early Clinical Stage Products
8. Bronchiolitis Obliterans Therapeutics - Products under Development by Companies, Universities/Institutes

Companies Mentioned

• PARI Pharma GmbH
• APT (News - Alert) Pharmaceuticals, Inc.
• Pacific Therapeutics Ltd.

Drug Profiles with Product Descriptions, Mechanisms of Action and R&D Progress

• bortezomib
• cyclosporine
• interferon gamma-1b
• (pentoxifylline + N-acetylcysteine)

For more information visit http://www.researchandmarkets.com/research/xb4swd/bronchiolitis

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

[ Back To TMCnet.com's Homepage ]